{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:54:48Z","timestamp":1791111288220,"version":"4.1.0"},"reference-count":74,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Adverse effects are a common consequence of cytotoxic cancer treatments. Over the last two decades there have been significant advances in exploring the relationship between the gut microbiome and these adverse effects. Changes in the gut microbiome were shown in multiple clinical studies to be associated with the development of acute gastrointestinal adverse effects, including diarrhoea and mucositis. However, more recent studies showed that changes in the gut microbiome may also be associated with the long-term development of psychoneurological changes, cancer cachexia, and fatigue. Therefore, the aim of this review was to examine the literature to identify potential contributions and associations of the gut microbiome with the wide range of adverse effects from cytotoxic cancer treatments.<\/jats:p>","DOI":"10.3390\/cancers15174301","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T08:51:14Z","timestamp":1693299074000},"page":"4301","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The Association between the Gut Microbiome and Development and Progression of Cancer Treatment Adverse Effects"],"prefix":"10.3390","volume":"15","author":[{"given":"Amanda S.","family":"Maddern","sequence":"first","affiliation":[{"name":"School of Allied Health Science and Practice, The University of Adelaide, Adelaide, SA 5005, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8273-5048","authenticated-orcid":false,"given":"Janet K.","family":"Coller","sequence":"additional","affiliation":[{"name":"School of Biomedicine, The University of Adelaide, Adelaide, SA 5005, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Bowen","sequence":"additional","affiliation":[{"name":"School of Biomedicine, The University of Adelaide, Adelaide, SA 5005, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J.","family":"Gibson","sequence":"additional","affiliation":[{"name":"School of Allied Health Science and Practice, The University of Adelaide, Adelaide, SA 5005, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0025-7125(16)31407-9","article-title":"Intestinal microflora","volume":"66","author":"Simon","year":"1982","journal-title":"Med. Clin. N. Am."},{"key":"ref_2","first-page":"259","article-title":"Chemotherapy-induced mucositis: The role of gastrointestinal microflora and mucins in the luminal environment","volume":"5","author":"Stringer","year":"2007","journal-title":"J. Support Oncol."},{"key":"ref_3","first-page":"117","article-title":"The physiological importance of the colonic microflora","volume":"77","author":"Gustafsson","year":"1982","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cell.2006.02.017","article-title":"Ecological and evolutionary forces shaping microbial diversity in the human intestine","volume":"124","author":"Ley","year":"2006","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/nutrit\/nuw023","article-title":"Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease","volume":"74","author":"Pistollato","year":"2016","journal-title":"Nutr. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrgastro.2010.172","article-title":"The role of the gut microbiota in nonalcoholic fatty liver disease","volume":"7","author":"Quigley","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1078\/1438-4221-00246","article-title":"Intestinal flora and mucosal immune responses","volume":"293","author":"Heller","year":"2003","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrmicro.2017.44","article-title":"Anticancer effects of the microbiome and its products","volume":"15","author":"Zitvogel","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3389\/fmicb.2019.01050","article-title":"Gut microbiota shapes the efficiency of cancer therapy","volume":"10","author":"Ma","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1136\/gutjnl-2020-321153","article-title":"The role of gut microbiota in cancer treatment: Friend or foe?","volume":"69","author":"Cheng","year":"2020","journal-title":"Gut"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"E559","DOI":"10.1111\/1469-0691.12287","article-title":"Oral bacterial community dynamics in paediatric patients with malignancies in relation to chemotherapy-related oral mucositis: A prospective study","volume":"19","author":"Ye","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1158\/1078-0432.CCR-20-3445","article-title":"Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study","volume":"27","author":"Yi","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Fernandes, D., and Andreyev, J. (2022). The Role of the Human Gut Microbiome in Inflammatory Bowel Disease and Radiation Enteropathy. Microorganisms, 10.","DOI":"10.3390\/microorganisms10081613"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Al-Qadami, G.H., Secombe, K.R., Subramaniam, C.B., Wardill, H.R., and Bowen, J.M. (2022). Gut Microbiota-Derived Short-Chain Fatty Acids: Impact on Cancer Treatment Response and Toxicities. Microorganisms, 10.","DOI":"10.3390\/microorganisms10102048"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Li, Z., Ke, X., Zuo, D., Wang, Z., Fang, F., and Li, B. (2022). New Insights into the Relationship between Gut Microbiota and Radiotherapy for Cancer. Nutrients, 15.","DOI":"10.3390\/nu15010048"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00520-022-07559-5","article-title":"Baseline gut microbiota composition is associated with oral mucositis and tumour recurrence in patients with head and neck cancer: A pilot study","volume":"31","author":"Bowen","year":"2023","journal-title":"Support. Care Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wang, A., Ling, Z., Yang, Z., Kiela, P.R., Wang, T., Wang, C., Cao, L., Geng, F., Shen, M., and Ran, X. (2015). Gut Microbial Dysbiosis May Predict Diarrhea and Fatigue in Patients Undergoing Pelvic Cancer Radiotherapy: A Pilot Study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0126312"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1007\/s00520-021-06013-2","article-title":"Gut microbiota and fatigue in rectal cancer patients: A cross-sectional pilot study","volume":"29","author":"Lim","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbi.2019.02.025","article-title":"Impact of chemotherapy on the association between fear of cancer recurrence and the gut microbiota in breast cancer survivors","volume":"85","author":"Okubo","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"19547","DOI":"10.1038\/s41598-022-23793-7","article-title":"Impacts of breast cancer and chemotherapy on gut microbiome, cognitive functioning, and mood relative to healthy controls","volume":"12","author":"Bilenduke","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/jcsm.12804","article-title":"Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients","volume":"12","author":"Ubachs","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Hakozaki, T., Nolin-Lapalme, A., Kogawa, M., Okuma, Y., Nakamura, S., Moreau-Amaru, D., Tamura, T., Hosomi, Y., Takeyama, H., and Richard, C. (2022). Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis. Cancers, 14.","DOI":"10.3390\/cancers14215405"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00520-013-1741-7","article-title":"Biomarkers of chemotherapy-induced diarrhoea: A clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases","volume":"21","author":"Stringer","year":"2013","journal-title":"Support. Care Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1111\/jcmm.14289","article-title":"Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy","volume":"23","author":"Wang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1158\/1078-0432.CCR-19-0960","article-title":"Microbiota-and radiotherapy-induced gastrointestinal side-effects (MARS) study: A large pilot study of the microbiome in acute and late-radiation enteropathy","volume":"25","author":"Andreyev","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1007\/s00520-019-04893-z","article-title":"The pathogenesis of mucositis: Updated perspectives and emerging targets","volume":"27","author":"Bowen","year":"2019","journal-title":"Support. Care Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/pr.118.015768","article-title":"Gut Reactions: Breaking Down Xenobiotic\u2013Microbiome Interactions","volume":"71","author":"Clarke","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MOG.0000000000000139","article-title":"The gut microbiome in health and in disease","volume":"31","author":"Shreiner","year":"2015","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/phar.2731","article-title":"Gut microbiome health and dysbiosis: A clinical primer","volume":"42","author":"Bidell","year":"2022","journal-title":"Pharmacotherapy"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/apt.13302","article-title":"Chemotherapy-driven dysbiosis in the intestinal microbiome","volume":"42","author":"Montassier","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00520-016-3568-5","article-title":"Gut microbiota composition associated with alterations in cardiorespiratory fitness and psychosocial outcomes among breast cancer survivors","volume":"25","author":"Paulsen","year":"2017","journal-title":"Support. Care Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","article-title":"Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism","volume":"7","author":"Morrison","year":"2016","journal-title":"Gut Microbes."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1055\/s-0042-121493","article-title":"Short-chain fatty acids inhibit oxidative stress and inflammation in mesangial cells induced by high glucose and lipopolysaccharide","volume":"125","author":"Huang","year":"2017","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13014-020-01735-9","article-title":"Radiotherapy and the gut microbiome: Facts and fiction","volume":"16","author":"Liu","year":"2021","journal-title":"Radiat. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jamaoncol.2022.0494","article-title":"The potential of the gut microbiome to reshape the cancer therapy paradigm: A review","volume":"8","author":"Liu","year":"2022","journal-title":"JAMA Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity","volume":"14","author":"Alexander","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"104197","DOI":"10.1016\/j.ebiom.2022.104197","article-title":"Effects of microbiota on anticancer drugs: Current knowledge and potentilal applications","volume":"83","author":"Huang","year":"2022","journal-title":"EBioMedicine"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Rajagopala, S.V., Yooseph, S., Harkins, D.M., Moncera, K.J., Zabokrtsky, K.B., Torralba, M.G., Tovchigrechko, A., Highlander, S.K., Pieper, R., and Sender, L. (2016). Gastrointestinal microbial populations can distinguish pediatric and adolescent Acute Lymphoblastic Leukemia (ALL) at the time of disease diagnosis. BMC Genom., 17.","DOI":"10.1186\/s12864-016-2965-y"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"El Alam, M.B., Sims, T.T., Kouzy, R., Biegert, G.W., Jaoude, J.A., Karpinets, T.V., Yoshida-Court, K., Wu, X., Delgado-Medrano, A.Y., and Mezzari, M.P. (2021). A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0247905"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/jop.12152","article-title":"The role of oral flora in the development of chemotherapy-induced oral mucositis","volume":"44","author":"Stringer","year":"2015","journal-title":"J. Oral. Pathol. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1007\/s00520-019-04892-0","article-title":"Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines","volume":"27","author":"Bowen","year":"2019","journal-title":"Support. Care Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1111\/j.1572-0241.2008.01868.x","article-title":"The Gut Microbiota Predispose to the Pathophysiology of Acute Postradiotherapy Diarrhea","volume":"103","author":"Manichanh","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"562463","DOI":"10.3389\/fcimb.2020.562463","article-title":"The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients-A Pilot Study","volume":"10","author":"Shi","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41523-022-00455-5","article-title":"Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy","volume":"8","author":"Aarnoutse","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1002\/cncr.33100","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"126","author":"Elad","year":"2020","journal-title":"Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tripleo.2005.12.016","article-title":"Relationship between mucositis and changes in oral microflora during cancer chemotherapy","volume":"103","author":"Brennan","year":"2007","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/ijc.30252","article-title":"Cytokine-mediated blood brain barrier disruption as a conduit for cancer\/chemotherapy-associated neurotoxicity and cognitive dysfunction","volume":"139","author":"Wardill","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnbeh.2018.00104","article-title":"From the bottom-up: Chemotherapy and gut-brain axis dysregulation","volume":"12","author":"Bajic","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"105640","DOI":"10.1016\/j.psyneuen.2021.105640","article-title":"The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: A systematic review","volume":"137","author":"Barrio","year":"2022","journal-title":"Psychoneuroendocrinology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fendo.2020.00025","article-title":"The role of short-chain fatty acids from gut microbiota in gut-brain communication","volume":"11","author":"Silva","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"104578","DOI":"10.1016\/j.nbd.2019.104578","article-title":"Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience","volume":"135","author":"Flux","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.3390\/curroncol29050243","article-title":"The Chemo-Gut Pilot Study: Associations between Gastrointestinal and Psychosocial Symptoms, Gut Microbiota and Cortisol in Young Adult Cancer Survivors","volume":"29","author":"Deleemans","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00520-022-07496-3","article-title":"Health-related quality of life is associated with fecal microbial composition in breast cancer survivors","volume":"31","author":"Smith","year":"2023","journal-title":"Support. Care Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/rco2.30","article-title":"Mediators and clinical treatment for cancer cachexia: A systematic review","volume":"4","author":"Cao","year":"2021","journal-title":"JCSM Rapid. Commun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1038\/s41396-021-00998-8","article-title":"Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients","volume":"15","author":"Ni","year":"2021","journal-title":"ISME J"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1038\/s41598-021-84783-9","article-title":"Associations between the gut microbiome and fatigue in cancer patients","volume":"11","author":"Hajjar","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1007\/s00520-020-05820-3","article-title":"The role of the gut microbiome in cancer-related fatigue: Pilot study on epigenetic mechanisms","volume":"29","author":"Xiao","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/1759-7714.14765","article-title":"Diverse gut microbiota pattern between mild and severe cancer-related fatigue in lung cancer patients treated with first-line chemotherapy: A pilot study","volume":"14","author":"Wei","year":"2023","journal-title":"Thorac. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","article-title":"The microbiome, cancer, and cancer therapy","volume":"25","author":"Helmink","year":"2019","journal-title":"Nat. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"15347354211061733","DOI":"10.1177\/15347354211061733","article-title":"The Use of Prebiotic and Probiotic Interventions for Treating Gastrointestinal and Psychosocial Health Symptoms in Cancer Patients and Survivors: A Systematic Review","volume":"20","author":"Deleemans","year":"2021","journal-title":"Integr. Cancer Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.clnu.2013.10.015","article-title":"A randomized double-blind controlled trial: Impact of probiotics on diarrhea in patients treated with pelvic radiation","volume":"33","author":"Demers","year":"2014","journal-title":"Clin. Nutr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s12602-018-9408-9","article-title":"Effect of Probiotics for the Prevention of Acute Radiation-Induced Diarrhoea Among Cervical Cancer Patients: A Randomized Double-Blind Placebo-Controlled Study","volume":"11","author":"Linn","year":"2019","journal-title":"Probiotics. Antimicrob. Proteins."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jpen.1987","article-title":"Randomized Controlled Trial on the Effect of Partially Hydrolyzed Guar Gum Supplementation on Diarrhea Frequency and Gut Microbiome Count Among Pelvic Radiation Patients","volume":"45","author":"Rosli","year":"2021","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4103\/jcrt.JCRT_152_19","article-title":"A phase 2 randomized controlled trial of oral resistant starch supplements in the prevention of acute radiation proctitis in patients treated for cervical cancer","volume":"15","author":"Sasidharan","year":"2019","journal-title":"J. Cancer Res. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1080\/00365520902839675","article-title":"Fructo-oligosaccharides and fibre in enteral nutrition has a beneficial influence on microbiota and gastrointestinal quality of life","volume":"44","author":"Wierdsma","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s00595-010-4450-6","article-title":"Functional outcome, quality of life, and efficacy of probiotics in postoperative patients with colorectal cancer","volume":"41","author":"Ohigashi","year":"2011","journal-title":"Surg. Today"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.dld.2014.09.004","article-title":"Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: A double-blind, randomized, placebo-controlled trial","volume":"46","author":"Lee","year":"2014","journal-title":"Dig Liver Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/codi.15463","article-title":"Effects of probiotics on bowel function restoration following ileostomy closure in rectal cancer patients: A randomized controlled trial","volume":"23","author":"Yoon","year":"2021","journal-title":"Colorectal. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejca.2021.11.006","article-title":"Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: A randomised, double-blind, and placebo-controlled trial","volume":"161","author":"Juan","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Knisely, A., Seo, Y.D., Wargo, J.A., and Chelvanambi, M. (2023). Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment. Cancers, 15.","DOI":"10.3390\/cancers15030777"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Zeng, H., Umar, S., Rust, B., Lazarova, D., and Bordonaro, M. (2019). Secondary Bile Acids and Short Chain Fatty Acids in the Colon: A Focus on Colonic Microbiome, Cell Proliferation, Inflammation, and Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20051214"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.canlet.2021.11.027","article-title":"Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?","volume":"526","author":"Hou","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-023-01406-7","article-title":"Role of the gut microbiota in anticancer therapy: From molecular mechanisms to clinical applications","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal. Transduct. Target. Ther."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/17\/4301\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:41:11Z","timestamp":1760128871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/17\/4301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":74,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["cancers15174301"],"URL":"https:\/\/doi.org\/10.3390\/cancers15174301","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,28]]}}}